Literature DB >> 23852922

Cholinergic circuitry of the human nucleus basalis and its fate in Alzheimer's disease.

M-Marsel Mesulam1.   

Abstract

The nucleus basalis is located at the confluence of the limbic and reticular activating systems. It receives dopaminergic input from the ventral tegmental area/substantia nigra, serotonergic input from the raphe nuclei, and noradrenergic input from the nucleus locus coeruleus. Its cholinergic contingent, known as Ch4, provides the principal source of acetylcholine for the cerebral cortex and amygdala. More than half of presynaptic varicosities along its cholinergic axons make traditional synaptic contacts with cortical neurons. Limbic and paralimbic cortices of the brain receive the heaviest cholinergic input from Ch4 and are also the principal sources of reciprocal cortical projections back to the nucleus basalis. This limbic affiliation explains the role of the nucleus basalis in modulating the impact and memorability of incoming sensory information. The anatomical continuity of the nucleus basalis with other basomedial limbic structures may underlie its early and high vulnerability to the tauopathy and neurofibrillary degeneration of Alzheimer's disease. The tauopathy in Ch4 eventually leads to the degeneration of the cholinergic axons that it sends to the cerebral cortex. The early involvement of Ch4 has a magnifying effect on Alzheimer's pathology, because neurofibrillary degeneration in a small number of neurons can perturb neurotransmission in all cortical areas. Although the exact contribution of the Ch4 lesion to the cognitive changes of Alzheimer's disease remains poorly understood, the cholinergic circuitry of the nucleus basalis is emerging as one of the most strategically positioned and behaviorally consequential modulatory systems of the human cerebral cortex. J. Comp. Neurol. 521:4124-4144, 2013. © 2013 Wiley Periodicals, Inc.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  Alzheimer's disease; cholinergic circuitry; nucleus basalis

Mesh:

Year:  2013        PMID: 23852922      PMCID: PMC4175400          DOI: 10.1002/cne.23415

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  84 in total

1.  Differential cholinergic innervation within functional subdivisions of the human cerebral cortex: a choline acetyltransferase study.

Authors:  M M Mesulam; L B Hersh; D C Mash; C Geula
Journal:  J Comp Neurol       Date:  1992-04-15       Impact factor: 3.215

2.  Neural pathway from nucleus basalis of Meynert passing through the cingulum in the human brain.

Authors:  Ji Heon Hong; Sung Ho Jang
Journal:  Brain Res       Date:  2010-06-04       Impact factor: 3.252

3.  Three-dimensional representation and cortical projection topography of the nucleus basalis (Ch4) in the macaque: concurrent demonstration of choline acetyltransferase and retrograde transport with a stabilized tetramethylbenzidine method for horseradish peroxidase.

Authors:  M M Mesulam; E J Mufson; B H Wainer
Journal:  Brain Res       Date:  1986-03-05       Impact factor: 3.252

4.  Architecture of connectivity within a cingulo-fronto-parietal neurocognitive network for directed attention.

Authors:  R J Morecraft; C Geula; M M Mesulam
Journal:  Arch Neurol       Date:  1993-03

5.  Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.

Authors:  Steven T DeKosky; Milos D Ikonomovic; Scot D Styren; Laurel Beckett; Stephen Wisniewski; David A Bennett; Elizabeth J Cochran; Jeffrey H Kordower; Elliott J Mufson
Journal:  Ann Neurol       Date:  2002-02       Impact factor: 10.422

6.  Nucleus basalis neurons exhibit axonal branching with decreased impulse conduction velocity in rat cerebrocortex.

Authors:  G Aston-Jones; R Shaver; T G Dinan
Journal:  Brain Res       Date:  1985-01-28       Impact factor: 3.252

7.  Overlap between acetylcholinesterase-rich and choline acetyltransferase-positive (cholinergic) axons in human cerebral cortex.

Authors:  M M Mesulam; C Geula
Journal:  Brain Res       Date:  1992-04-10       Impact factor: 3.252

8.  Two types of muscarinic response to acetylcholine in mammalian cortical neurons.

Authors:  D A McCormick; D A Prince
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

Review 9.  From sensation to cognition.

Authors:  M M Mesulam
Journal:  Brain       Date:  1998-06       Impact factor: 13.501

10.  Cholinergic neuronal and axonal abnormalities are present early in aging and in Alzheimer disease.

Authors:  Changiz Geula; Nicholas Nagykery; Alexander Nicholas; Chuang-Kuo Wu
Journal:  J Neuropathol Exp Neurol       Date:  2008-04       Impact factor: 3.685

View more
  93 in total

Review 1.  Modulation of Human Memory by Deep Brain Stimulation of the Entorhinal-Hippocampal Circuitry.

Authors:  Emily A Mankin; Itzhak Fried
Journal:  Neuron       Date:  2020-04-22       Impact factor: 17.173

Review 2.  The cholinergic system in the pathophysiology and treatment of Alzheimer's disease.

Authors:  Harald Hampel; M-Marsel Mesulam; A Claudio Cuello; Martin R Farlow; Ezio Giacobini; George T Grossberg; Ara S Khachaturian; Andrea Vergallo; Enrica Cavedo; Peter J Snyder; Zaven S Khachaturian
Journal:  Brain       Date:  2018-07-01       Impact factor: 13.501

Review 3.  Neuropsychiatric symptoms in Alzheimer's disease: What might be associated brain circuits?

Authors:  Paul B Rosenberg; Milap A Nowrangi; Constantine G Lyketsos
Journal:  Mol Aspects Med       Date:  2015-06-03

4.  Cholinergic Mechanisms in the Cerebral Cortex: Beyond Synaptic Transmission.

Authors:  Saak V Ovsepian; Valerie B O'Leary; Laszlo Zaborszky
Journal:  Neuroscientist       Date:  2015-05-22       Impact factor: 7.519

5.  Altered Cortical and Hippocampal Excitability in TgF344-AD Rats Modeling Alzheimer's Disease Pathology.

Authors:  Milan Stoiljkovic; Craig Kelley; Bernardo Stutz; Tamas L Horvath; Mihály Hajós
Journal:  Cereb Cortex       Date:  2019-06-01       Impact factor: 5.357

Review 6.  Nicotinic ACh receptors as therapeutic targets in CNS disorders.

Authors:  Kelly T Dineley; Anshul A Pandya; Jerrel L Yakel
Journal:  Trends Pharmacol Sci       Date:  2015-01-29       Impact factor: 14.819

7.  Alpha rhythm oscillations and MMSE scores are differently modified by transdermal or oral rivastigmine in patients with Alzheimer's disease.

Authors:  Davide V Moretti
Journal:  Am J Neurodegener Dis       Date:  2014-09-06

Review 8.  Nicotinic Acetylcholine Receptor Agonists for the Treatment of Alzheimer's Dementia: An Update.

Authors:  Justin L Hoskin; Yazan Al-Hasan; Marwan Noel Sabbagh
Journal:  Nicotine Tob Res       Date:  2019-02-18       Impact factor: 4.244

9.  Frontal cortex and striatal cellular and molecular pathobiology in individuals with Down syndrome with and without dementia.

Authors:  Sylvia E Perez; Jennifer C Miguel; Bin He; Michael Malek-Ahmadi; Eric E Abrahamson; Milos D Ikonomovic; Ira Lott; Eric Doran; Melissa J Alldred; Stephen D Ginsberg; Elliott J Mufson
Journal:  Acta Neuropathol       Date:  2019-02-07       Impact factor: 17.088

10.  Multimodal Encoding of Novelty, Reward, and Learning in the Primate Nucleus Basalis of Meynert.

Authors:  Clarissa Martinez-Rubio; Angelique C Paulk; Eric J McDonald; Alik S Widge; Emad N Eskandar
Journal:  J Neurosci       Date:  2018-01-18       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.